| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥12199.0B | ¥11066.9B | +10.2% |
| Operating Income | ¥2014.2B | ¥1845.7B | +9.1% |
| Profit Before Tax | ¥1627.2B | ¥1506.3B | +8.0% |
| Net Income | ¥1132.6B | ¥1242.8B | -8.9% |
| ROE | 1.5% | 1.7% | - |
While Revenue and Operating Income achieved double-digit and single-digit growth, respectively, Net Income declined due to the increased tax burden, resulting in divergence across profit levels. Revenue was ¥12,199.0B (¥11,066.9B in the previous year, YoY+10.2%), and Operating Income was ¥2,014.2B (up +9.1%), securing higher revenue and profit. However, Net Income attributable to owners of the parent was ¥1,132.0B (¥1,242.4B in the previous year, YoY-8.9%), representing a decline. The Operating Income margin was 16.5%, nearly unchanged from 16.7% in the previous year, while the Net Income margin decreased to 9.3% from 11.2%, primarily due to the increase in the effective tax rate to 30.4% from 17.5% in the previous year.
【Revenue】Revenue was ¥12,199.0B, up +10.2% year on year. The Company manages research and development, manufacturing, and sales of pharmaceutical products as a single business segment, and does not disclose a segment-level breakdown of Revenue. The cost of sales ratio improved to 33.3% from 34.8% in the previous year, and the product mix remained at a favorable level.
【Profit and Loss】Operating Income was ¥2,014.2B, up +9.1% year on year, slightly below the rate of Revenue growth. The selling, general and administrative expense ratio increased to 23.5% from 23.1%, while the research and development expense ratio rose to 13.7% from 13.0%, indicating that growth investments were front-loaded on the cost side. Amortization of product-related intangible assets decreased to ¥1,109.3B from ¥1,316.4B in the previous year. Meanwhile, impairment losses increased to ¥300.0B from ¥23.6B, and other operating expenses expanded to ¥552.3B from ¥280.6B. Profit Before Tax was ¥1,627.2B (+8.0%), but finance income declined significantly to ¥246.1B from ¥737.6B in the previous year, while the net burden of finance income and expenses increased to ¥392.4B from ¥334.0B. Income taxes were ¥494.6B (¥263.5B in the previous year), and the effective tax rate rose substantially to 30.4% from 17.5%, resulting in Net Income declining by -8.9% despite Profit Before Tax growth of +8.0%. In conclusion, the Company achieved higher Revenue and Operating Income, but final profit declined due to the increased net finance burden and higher effective tax rate.
【Profitability】The Operating Income margin was 16.5% (16.7% in the previous year), the Net Income margin was 9.3% (11.2% in the previous year), and the cost of sales ratio was 33.3% (improved from 34.8% in the previous year), indicating that core gross-profit-level profitability has been maintained.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥1,276.2B (down -40.8% year on year), and its ratio to Net Income of ¥1,132.0B was 1.13x, which is sound by definition, although deterioration in working capital was a downward factor.【Investment Efficiency】ROE was 1.5% (quarterly result, before annualization), indicating that capital efficiency remained limited relative to Operating Income growth.【Financial Soundness】The Equity Ratio was 48.3%, improving from 47.9% at the end of the same quarter of the previous year. Cash and cash equivalents were ¥460.98B (¥595.05B in the previous year), while bonds and borrowings totaled approximately ¥4,940.0B, comprising current liabilities of ¥519.97B and non-current liabilities of ¥4,420.0B.
Operating Cash Flow (OCF) was ¥1,276.2B, a significant decrease of -40.8% year on year. Its ratio to Net Income of ¥1,132.0B was 1.13x, favorable by definition; however, strong working-capital headwinds—including increases of ¥709.7B in trade and other receivables and ¥334.1B in inventories, as well as a ¥229.1B decrease in trade and other payables—constrained actual cash generation. Investing Cash Flow was -¥877.0B, with the primary expenditures consisting of ¥538.1B for the acquisition of property, plant and equipment and ¥494.3B for the acquisition of intangible assets. Financing Cash Flow was -¥1,803.5B, primarily reflecting dividend payments of ¥1,501.3B, while share repurchases were limited to ¥1.1B. As a result, Free Cash Flow (OCF + Investing Cash Flow) was ¥399.2B, substantially below the dividend payments of ¥1,501.3B during the quarter. Cash and cash equivalents decreased from ¥595.1B at the beginning of the period to ¥460.98B at period-end, although there was a positive foreign currency translation impact of ¥63.5B.
The gap between Operating Income of ¥2,014.2B and Profit Before Tax of ¥1,627.2B was attributable to the net finance burden of ¥392.4B, comprising finance income of ¥246.1B and finance expenses of ¥638.5B; this net burden increased from ¥334.0B in the previous year. The Company recorded impairment losses of ¥300.0B during the current period, up from ¥23.6B in the previous year, which should be distinguished as a non-recurring factor. The effective tax rate rose substantially to 30.4% from 17.5% in the previous year, becoming the primary factor behind the decline in Net Income of -8.9% despite Profit Before Tax growth of +8.0%. Meanwhile, comprehensive income was ¥2,713.0B (¥1,191.0B in the previous year), substantially exceeding Net Income of ¥1,132.6B. This was because foreign currency translation adjustments for foreign operations contributed a positive ¥1,633.0B, with foreign-exchange valuation-related OCI items serving as the primary driver. Accordingly, the significant increase in comprehensive income does not indicate an improvement in the Company’s recurring earnings power; the divergence from Net Income largely reflects accrual-related factors arising from fluctuations in yen-denominated valuation.
The full-year forecast is Revenue of ¥46,400.0B, Operating Income of ¥4,200.0B, Net Income attributable to owners of the parent of ¥1,660.0B, EPS of ¥104.26, and dividends of ¥102, with no revisions to the earnings or dividend forecasts for the current quarter. As of Q1, progress rates were 26.3% for Revenue (12,199.0/46,400.0), 47.9% for Operating Income (2,014.2/4,200.0), and 68.2% for Net Income (1,132.0/1,660.0). While progress in Revenue and Operating Income is only slightly above the quarterly run-rate of 25%, the relatively high progress in Net Income suggests that the full-year Net Income forecast has been set conservatively relative to the previous year’s actual result. Trends in the tax burden and finance expenses during the second half will be key to achieving the full-year targets.
The full-year dividend forecast is ¥102, an increase of ¥2 from the previous year’s actual dividend of ¥100. The Payout Ratio against forecast EPS of ¥104.26 is high at 97.8% (¥102/¥104.26). Share repurchases were ¥1.1B during the quarter, a substantial decrease from ¥516.3B in the same quarter of the previous year, resulting in a shareholder-return structure centered on dividends. Free Cash Flow of ¥399.2B during the quarter was below dividend payments of ¥1,501.3B, indicating that dividends were not fully covered by cash flow for the individual quarter; this warrants monitoring. However, the Company held cash and cash equivalents of ¥460.98B, and an assessment should take into account cash generation trends for the full year.
Goodwill and Intangible Asset Impairment Risk: Goodwill was ¥58,869.1B and intangible assets were ¥33,911.5B, together accounting for approximately 59% of total assets of ¥156,632.7B and approximately 123% of net assets of ¥75,588.8B. Impairment losses during the quarter increased to ¥300.0B from ¥23.6B in the previous year, and valuation fluctuations in M&A-derived assets may affect future earnings.
Risk of Increased Net Finance Burden and Effective Tax Rate: The net burden of finance income and expenses increased to ¥392.4B from ¥334.0B in the previous year, while the effective tax rate rose substantially to 30.4% from 17.5%. These factors contributed to pushing Net Income down to -8.9% growth despite Profit Before Tax growth of +8.0%, and changes in interest-rate and tax environments from the second half onward may become drivers of earnings volatility.
Deterioration in Working Capital and Slower Cash Generation: Trade receivables increased by ¥709.7B and inventories increased by ¥334.1B, while trade payables decreased by ¥229.1B, resulting in OCF declining by -40.8% year on year. Free Cash Flow of ¥399.2B was below dividend payments of ¥1,501.3B, and the direction of working-capital normalization will determine future cash flow levels.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 16.5% | 17.5% (6.9%–23.1%) | -1.0pt |
| Net Income Margin | 9.3% | 8.9% (2.5%–15.6%) | +0.4pt |
The Operating Income margin is slightly below the industry median, while the Net Income margin exceeds the median, placing overall profitability at a mid-range level within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (Year on Year) | 10.2% | 9.8% (2.9%–13.0%) | +0.3pt |
The Revenue growth rate is slightly above the industry median, indicating that top-line growth is at a standard level within the industry.
※Source: Compiled by the Company
Although the Company maintained a trend of higher Revenue and Operating Income, Net Income declined by -8.9% due to the increased net finance burden and higher effective tax rate (30.4%, versus 17.5% in the previous year), with divergence between profit levels being the defining feature of these earnings results.
Goodwill and intangible assets account for approximately 59% of total assets, and impairment losses during the quarter increased year on year, indicating that sensitivity to valuation fluctuations in the asset composition remains somewhat high.
The Payout Ratio was high at 97.8%, and Free Cash Flow during the quarter was below dividend payments. The relationship between full-year cash generation and shareholder returns will therefore continue to warrant close monitoring.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation to undertake any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥3,933 |
| base | ¥3,986 |
| bull | ¥4,004 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | ¥4,783 |
| Adjusted Forecast EPS | ¥114.7 |
| Cost of Equity r | 8.65% (10-year Japanese government bond 2.65% + equity risk premium 6.00% + size premium 0.00%) |
| Residual Income Persistence Coefficient ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 97.8% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on progress ahead of the full-year forecast) |
| Implied PBR / PER |
Sensitivity: ¥3,880–¥4,097 at a ±1% change in the cost of equity, and ¥3,961–¥4,002 at a ±0.1 change in ω.
Notes:
(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This value does not forecast or guarantee the future share price)
This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings-summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.
| 0.83x / 34.8x |
These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.